{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T15:31:35Z","timestamp":1763479895778,"version":"3.40.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.pnpbp.2013.02.011","type":"journal-article","created":{"date-parts":[[2013,2,26]],"date-time":"2013-02-26T13:45:15Z","timestamp":1361886315000},"page":"178-183","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Loss of dopamine neuron terminals in antipsychotic-treated schizophrenia; relation to tardive dyskinesia"],"prefix":"10.1016","volume":"44","author":[{"given":"Philip","family":"Seeman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Tinazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pnpbp.2013.02.011_bb0005","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.biopsych.2009.08.036","article-title":"Genomewide association study of movement-related adverse antipsychotic effects","volume":"67","author":"Aberg","year":"2010","journal-title":"Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2013.02.011_bb0010","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/sj.mp.4002142","article-title":"Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactions","volume":"13","author":"Bakker","year":"2008","journal-title":"Mol Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2013.02.011_bb0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/syn.20825","article-title":"Antipsychotic drug binding in the substantia nigra: an examination of high metoclopramide binding in the brains of normal, Alzheimer's disease, Huntington's disease, and multiple sclerosis patients, and its relation to tardive dyskinesia","volume":"65","author":"Chen","year":"2011","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2013.02.011_bb0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0447.1970.tb02097.x","article-title":"Neuropathological investigation of 28 brains from patients with dyskinesia","volume":"46","author":"Christensen","year":"1970","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2013.02.011_bb0025","first-page":"16","article-title":"Tardive dyskinesia in schizophrenic outpatients: prevalence and significant variables","volume":"42","author":"Ezrin-Waters","year":"1981","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2013.02.011_bb0030","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/(SICI)1098-2396(199806)29:2<128::AID-SYN4>3.0.CO;2-9","article-title":"Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters","volume":"29","author":"Fischman","year":"1998","journal-title":"Synapse"},{"issue":"3","key":"10.1016\/j.pnpbp.2013.02.011_bb0035","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.parkreldis.2010.11.019","article-title":"Managing idiopathic Parkinson's disease in patients with schizophrenic disorders","volume":"17","author":"Friedman","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"10.1016\/j.pnpbp.2013.02.011_bb0040","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/schbul\/sbr111","article-title":"Striatal presynaptic dopamine in schizophrenia, part I: meta-analysis of dopamine active transporter (DAT) density","volume":"39","author":"Fusar-Poli","year":"2013","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2013.02.011_bb0045","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.11.2011.5108","article-title":"Schizophrenia and Parkinson's disease: challenges in management","author":"Gadit","year":"2011","journal-title":"BMJ Case Rep"},{"issue":"12","key":"10.1016\/j.pnpbp.2013.02.011_bb0050","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/archinte.1993.00410120051007","article-title":"The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders","volume":"153","author":"Ganzini","year":"1993","journal-title":"Arch Intern Med"},{"issue":"16","key":"10.1016\/j.pnpbp.2013.02.011_bb0055","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1002\/mds.23377","article-title":"Evidence for association of the GLI2 gene with tardive dyskinesia in patients with chronic schizophrenia","volume":"25","author":"Greenbaum","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.pnpbp.2013.02.011_bb0060","article-title":"Support for association of HSPG2 with tardive dyskinesia in Caucasian populations","author":"Greenbaum","year":"2011","journal-title":"Pharmacogenomics J"},{"issue":"3","key":"10.1016\/j.pnpbp.2013.02.011_bb0065","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1176\/jnp.2008.20.3.373","article-title":"Psychosis in a case of schizophrenia and Parkinson's disease","volume":"20","author":"Habermeyer","year":"2008","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"3\u20134","key":"10.1016\/j.pnpbp.2013.02.011_bb0070","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000113678","article-title":"Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness","volume":"5","author":"Hornykiewicz","year":"2008","journal-title":"Neurodegener Dis"},{"issue":"1","key":"10.1016\/j.pnpbp.2013.02.011_bb0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0920-9964(03)00006-9","article-title":"Dopamine transporter change in drug-naive schizophrenia: an imaging study with 99mTc-TRODAT-1","volume":"65","author":"Hsiao","year":"2003","journal-title":"Schizophr Res"},{"issue":"4","key":"10.1016\/j.pnpbp.2013.02.011_bb0080","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/syn.20603","article-title":"Regional analysis of age-related decline in dopamine transporters and dopamine D2-like receptors in human striatum","volume":"63","author":"Ishibashi","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2013.02.011_bb0085","series-title":"Neurotoxicology","first-page":"25","article-title":"Neuropathologic findings after neuroleptic long-term therapy","author":"Jellinger","year":"1977"},{"key":"10.1016\/j.pnpbp.2013.02.011_bb0090","first-page":"16","article-title":"Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence","volume":"65","author":"Kane","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"7\u20138","key":"10.1016\/j.pnpbp.2013.02.011_bb0095","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/BF03033449","article-title":"Binding of 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]pyridinium ion (HPP+), a metabolite of haloperidol, to synthetic melanin: implications for the dopaminergic neurotoxicity of HPP+","volume":"6","author":"Kawashima","year":"2004","journal-title":"Neurotox Res"},{"key":"10.1016\/j.pnpbp.2013.02.011_bb0100","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/0091270007312258","article-title":"Metoclopramide, an increasingly recognized cause of tardive dyskinesia","volume":"48","author":"Kenney","year":"2008","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.pnpbp.2013.02.011_bb0105","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1176\/appi.ajp.157.2.269","article-title":"Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography","volume":"157","author":"Laakso","year":"2000","journal-title":"Am J Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2013.02.011_bb0110","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0920-9964(00)00095-5","article-title":"Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia","volume":"52","author":"Laakso","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2013.02.011_bb0115","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/syn.21504","article-title":"Cell membrane lytic action of metoclopramide and its relation to tardive dyskinesia","volume":"66","author":"Lai","year":"2011","journal-title":"Synapse"},{"issue":"4","key":"10.1016\/j.pnpbp.2013.02.011_bb0120","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.genhosppsych.2011.02.006","article-title":"Treatment dilemma in comorbidity of schizophrenia and idiopathic Parkinson's disease","volume":"33","author":"Lan","year":"2011","journal-title":"Gen Hosp Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2013.02.011_bb0125","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00004647-200003000-00001","article-title":"Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review","volume":"20","author":"Laruelle","year":"2000","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"10.1016\/j.pnpbp.2013.02.011_bb0130","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s002590050044","article-title":"[123I]FP-CIT binding in rat brain after acute and sub-chronic administration of dopaminergic medication","volume":"27","author":"Lavalaye","year":"2000","journal-title":"Eur J Nucl Med"},{"issue":"7","key":"10.1016\/j.pnpbp.2013.02.011_bb0135","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s002590000279","article-title":"Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers","volume":"27","author":"Lavalaye","year":"2000","journal-title":"Eur J Nucl Med"},{"issue":"1","key":"10.1016\/j.pnpbp.2013.02.011_bb0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s002130000670","article-title":"Dopamine transporter density in patients with tardive dyskinesia: a single photon emission computed tomography study","volume":"155","author":"Lavalaye","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.pnpbp.2013.02.011_bb0145","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0920-9964(00)00023-2","article-title":"Dopamine transporter density in young patients with schizophrenia assessed with [123]FP-CIT SPECT","volume":"47","author":"Lavalaye","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2013.02.011_bb0150","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/B978-0-12-381328-2.00010-9","article-title":"Genetics of tardive dyskinesia","volume":"98","author":"Lee","year":"2011","journal-title":"Int Rev Neurobiol"},{"issue":"2","key":"10.1016\/j.pnpbp.2013.02.011_bb0155","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00213-005-2250-2","article-title":"Decreased striatal dopamine transporter binding assessed with [123I] FP-CIT in first-episode schizophrenic patients with and without short-term antipsychotic-induced parkinsonism","volume":"181","author":"Mateos","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.pnpbp.2013.02.011_bb0160","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00213-006-0570-5","article-title":"Lower striatal dopamine transporter binding in neuroleptic-naive schizophrenic patients is not related to antipsychotic treatment but it suggests an illness trait","volume":"191","author":"Mateos","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"issue":"11","key":"10.1016\/j.pnpbp.2013.02.011_bb0165","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/archinte.1989.00390110070015","article-title":"Metoclopramide-induced movement disorders. Clinical findings with a review of the literature","volume":"149","author":"Miller","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pnpbp.2013.02.011_bb0170","series-title":"The human central nervous system","first-page":"206","author":"Nieuwenhuys","year":"2008"},{"issue":"7","key":"10.1016\/j.pnpbp.2013.02.011_bb0175","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2967\/jnumed.109.061952","article-title":"Pretreatment with haloperidol reduces 123I-FP-CIT binding to the dopamine transporter in the rat striatum: an in vivo imaging study with a dedicated small-animal SPECT camera","volume":"50","author":"Nikolaus","year":"2009","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.pnpbp.2013.02.011_bb0180","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4306\/pi.2011.8.1.49","article-title":"No evidence for an association between dopamine D2 receptor polymorphisms and tardive dyskinesia in Korean schizophrenia patients","volume":"8","author":"Park","year":"2011","journal-title":"Psychiatry Investig"},{"issue":"16 Pt 2","key":"10.1016\/j.pnpbp.2013.02.011_bb0185","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1212\/01.wnl.0000285082.18969.3a","article-title":"Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation","volume":"70","author":"Rajput","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.pnpbp.2013.02.011_bb0190","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00406-011-0269-4","article-title":"Dual-isotope SPECT imaging of striatal dopamine: a comparative study between never-treated and haloperidol-treated first-episode schizophrenic patients","volume":"262","author":"Schmitt","year":"2012","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"4","key":"10.1016\/j.pnpbp.2013.02.011_bb0195","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0031-6997(25)06931-5","article-title":"The membrane actions of anesthetics and tranquilizers","volume":"24","author":"Seeman","year":"1972","journal-title":"Pharmacol Rev"},{"issue":"4 Suppl.","key":"10.1016\/j.pnpbp.2013.02.011_bb0200","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1097\/00004714-198808001-00002","article-title":"Tardive dyskinesia, dopamine receptors, and neuroleptic damage to cell membranes","volume":"8","author":"Seeman","year":"1988","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.02.011_bb0205","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1517\/14728222.10.4.515","article-title":"Targeting the dopamine D2 receptor in schizophrenia","volume":"10","author":"Seeman","year":"2006","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.pnpbp.2013.02.011_bb0210","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/syn.890030113","article-title":"Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain","volume":"3","author":"Seeman","year":"1989","journal-title":"Synapse"},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2013.02.011_bb0215","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.schres.2012.06.003","article-title":"[123I]FP-CIT single photon emission computed tomography findings in drug-induced parkinsonism","volume":"139","author":"Tinazzi","year":"2012","journal-title":"Schizophr Res"},{"issue":"1","key":"10.1016\/j.pnpbp.2013.02.011_bb0220","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0014-4800(70)90087-0","article-title":"Chlorpromazine and the eye of the dog. An electron microscopic study","volume":"13","author":"Tousimis","year":"1970","journal-title":"Exp Mol Pathol"},{"issue":"2","key":"10.1016\/j.pnpbp.2013.02.011_bb0225","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/syn.20708","article-title":"Dopamine transporter PET in normal aging: dopamine transporter decline and its possible role in preservation of motor function","volume":"64","author":"Troiano","year":"2010","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/j.pnpbp.2013.02.011_bb0230","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00019442-200201000-00005","article-title":"Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries","volume":"10","author":"Van Dyck","year":"2002","journal-title":"Am J Geriatr Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2013.02.011_bb0235","first-page":"554","article-title":"Dopamine transporters decrease with age","volume":"37","author":"Volkow","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pnpbp.2013.02.011_bb0240","doi-asserted-by":"crossref","first-page":"463","DOI":"10.4088\/JCP.07m03890yel","article-title":"Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study","volume":"71","author":"Woods","year":"2010","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"10.1016\/j.pnpbp.2013.02.011_bb0245","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1176\/appi.ajp.161.8.1496","article-title":"SPECT study. Associated alterations of striatal dopamine D2\/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study","volume":"161","author":"Yang","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2013.02.011_bb0250","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.schres.2004.03.015","article-title":"Dopamine transporter density in schizophrenic subjects with and without tardive dyskinesia","volume":"71","author":"Yoder","year":"2004","journal-title":"Schizophr Res"},{"issue":"5","key":"10.1016\/j.pnpbp.2013.02.011_bb0255","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1017\/S1461145706007152","article-title":"Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients","volume":"10","author":"Zai","year":"2007","journal-title":"Int J Neuropsychopharmacol"},{"issue":"9","key":"10.1016\/j.pnpbp.2013.02.011_bb0260","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/sj.mp.4002023","article-title":"Meta-analysis of two dopamine D2 receptor gene polymorphisms with tardive dyskinesia in schizophrenia patients","volume":"12","author":"Zai","year":"2007","journal-title":"Mol Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584613000456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584613000456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T22:13:05Z","timestamp":1745964785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584613000456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":52,"alternative-id":["S0278584613000456"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2013.02.011","relation":{},"ISSN":["0278-5846"],"issn-type":[{"type":"print","value":"0278-5846"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}